You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/69158
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBalbani, Aracy Pereira Silveira-
dc.contributor.authorStelzer, Lucilena Bardella-
dc.contributor.authorMontovani, Jair Cortez-
dc.date.accessioned2014-05-27T11:22:00Z-
dc.date.accessioned2016-10-25T18:22:48Z-
dc.date.available2014-05-27T11:22:00Z-
dc.date.available2016-10-25T18:22:48Z-
dc.date.issued2006-10-05-
dc.identifierhttp://dx.doi.org/10.1590/S0034-72992006000300018-
dc.identifier.citationRevista Brasileira de Otorrinolaringologia, v. 72, n. 3, p. 400-406, 2006.-
dc.identifier.issn0034-7299-
dc.identifier.urihttp://hdl.handle.net/11449/69158-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/69158-
dc.description.abstractAim: To evaluate the presence of preservatives, dyes, sweeteners and flavouring substances in 73 pharmaceutical preparations of 35 medicines for oral administration, according to drug labeling information about the excipients. Methods: 35 medications were selected, both over-the-counter and prescription durgs, marketed in Brazil. The sample included: analgesic/antipyretic, antimicrobial, mucoregulatory, cough and cold, decongestant, antihistamine, bronchodilator, corticosteroid, antiinflammatory and vitamin medications. We collected data on 73 preparations of these drugs, according to drug labeling information regarding preservatives, dyes, sweeteners and flavourings. Results: Methylparaben and propylparaben were the most common preservatives found (43% and 35.6% respectively). The most common sweeteners were: sucrose (sugar) (53.4%), sodium saccharin (38.3%) and sorbitol (36.9%). Twenty-one medicines (28,7%) contained two sweeteners. Colourless medicines predominated (43.8%), followed by those with sunset yellow dye (FD&C yellow no. 6) (15%). Five products (6.8%) contained more than one colour agent. Tartrazine (FD&C yellow no. 5) was present in seven preparations (9.5%). Fruit was the most common flavouring found (83%). Labelings of drugs which contained sugar frequently omitted its exact concentration (77%). Of the four labelings of medicines which contained aspartame, two did not warn patients regarding phenylketonuria. Conclusions: Omission and inacuracy of drug labeling information on pharmaceutical excipients may expose susceptible individuals to adverse reactions caused by preservatives and dyes. Complications of inadvertent intake of sugar-containing medicines by diabetics, or aspartame intake by patients with phenylketonuria may also occur.en
dc.format.extent400-406-
dc.language.isopor-
dc.sourceScopus-
dc.subjectDrug labeling-
dc.subjectFlavoring agents-
dc.subjectParabens-
dc.subjectPharmaceutic aids-
dc.subjectPharmaceutical preservatives-
dc.subjectTartrazine-
dc.subjectamoxicillin-
dc.subjectanalgesic agent-
dc.subjectantihistaminic agent-
dc.subjectantiinfective agent-
dc.subjectantiinflammatory agent-
dc.subjectantipyretic agent-
dc.subjectaspartame-
dc.subjectazithromycin-
dc.subjectbronchodilating agent-
dc.subjectcetirizine-
dc.subjectcoloring agent-
dc.subjectcorticosteroid-
dc.subjectdecongestive agent-
dc.subjectdrug additive-
dc.subjectebastine-
dc.subjectepinastine-
dc.subjectibuprofen-
dc.subjectloratadine-
dc.subjectmethyl paraben-
dc.subjectnimesulide-
dc.subjectparacetamol-
dc.subjectpreservative-
dc.subjectpropyl paraben-
dc.subjectsaccharin sodium-
dc.subjectsorbitol-
dc.subjectsucrose-
dc.subjectsunset yellow-
dc.subjecttartrazine-
dc.subjectunindexed drug-
dc.subjectvitamin-
dc.subjectaccuracy-
dc.subjectBrazil-
dc.subjectchemical composition-
dc.subjectconcentration (parameters)-
dc.subjectconsumer health information-
dc.subjectdrug formulary-
dc.subjectdrug information-
dc.subjectdrug labeling-
dc.subjectphenylketonuria-
dc.subjectColoring Agents-
dc.subjectDrug Labeling-
dc.subjectFlavoring Agents-
dc.subjectHumans-
dc.subjectPharmaceutic Aids-
dc.subjectPharmaceutical Preparations-
dc.subjectPreservatives, Pharmaceutical-
dc.subjectSweetening Agents-
dc.titleExcipientes de medicamentos e as informações da bulapt
dc.title.alternativePharmaceutical excipients and the information on drug labelsen
dc.typeoutro-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.description.affiliationHospital Das Clínicas Faculdade de Medicina de Botucatu (UNESP)-
dc.description.affiliationFaculdade de Medicina de Botucatu (UNESP)-
dc.description.affiliation, Rua Capitão Lisboa 715 cj. 33, Tatuí SP 18270-070-
dc.description.affiliationUnespHospital Das Clínicas Faculdade de Medicina de Botucatu (UNESP)-
dc.description.affiliationUnespFaculdade de Medicina de Botucatu (UNESP)-
dc.identifier.doi10.1590/S0034-72992006000300018-
dc.identifier.scieloS0034-72992006000300018-
dc.rights.accessRightsAcesso aberto-
dc.identifier.file2-s2.0-33749161876.pdf-
dc.relation.ispartofRevista Brasileira de Otorrinolaringologia-
dc.identifier.scopus2-s2.0-33749161876-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.